| Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a randomized, double-blind, placebo-controlled trial CJ Fisher, JFA Dhainaut, SM Opal, JP Pribble, RA Balk, GJ Slotman, ... Jama 271 (23), 1836-1843, 1994 | 1341 | 1994 |
| Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome JE Gadek, SJ DeMichele, MD Karlstad, ER Pacht, M Donahoe, ... Critical care medicine 27 (8), 1409-1420, 1999 | 1009 | 1999 |
| Factors associated with death in critically ill patients with coronavirus disease 2019 in the US S Gupta, SS Hayek, W Wang, L Chan, KS Mathews, ML Melamed, ... JAMA internal medicine 180 (11), 1436-1447, 2020 | 945 | 2020 |
| The stability of arterial blood gases during transportation of patients using the RespirTech PRO M Romano, OG Raabe, W Walby, TE Albertson The American journal of emergency medicine 18 (3), 273-277, 2000 | 923 | 2000 |
| Angiotensin II for the treatment of vasodilatory shock A Khanna, SW English, XS Wang, K Ham, J Tumlin, H Szerlip, LW Busse, ... New England Journal of Medicine 377 (5), 419-430, 2017 | 705 | 2017 |
| A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome A Khan, C Benthin, B Zeno, TE Albertson, J Boyd, JD Christie, R Hall, ... Critical care 21, 1-9, 2017 | 651 | 2017 |
| A multicenter study of physicians' knowledge of the pulmonary artery catheter TJ Iberti, EP Fischer, AB Leibowitz, EA Panacek, JH Silverstein, ... Jama 264 (22), 2928-2932, 1990 | 615 | 1990 |
| Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19 S Gupta, W Wang, SS Hayek, L Chan, KS Mathews, ML Melamed, ... JAMA internal medicine 181 (1), 41-51, 2021 | 513 | 2021 |
| Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F (ab′) 2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels EA Panacek, JC Marshall, TE Albertson, DH Johnson, S Johnson, ... Critical care medicine 32 (11), 2173-2182, 2004 | 395 | 2004 |
| Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial RD MacArthur, M Miller, T Albertson, E Panacek, D Johnson, L Teoh, ... Clinical infectious diseases 38 (2), 284-288, 2004 | 358 | 2004 |
| Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure R Hirschberg, J Kopple, P Lipsett, E Benjamin, J Minei, T Albertson, ... Kidney international 55 (6), 2423-2432, 1999 | 358 | 1999 |
| Pressure controlled inverse ratio ventilation in severe adult respiratory failure RS Tharratt, RP Alle, TE Albertson Chest 94 (4), 755-762, 1988 | 310 | 1988 |
| The asthma-COPD overlap syndrome: a common clinical problem in the elderly AA Zeki, M Schivo, A Chan, TE Albertson, S Louie Journal of allergy 2011, 2011 | 298 | 2011 |
| Methamphetamine and the expanding complications of amphetamines. TE Albertson, RW Derlet, BE Van Hoozen Western Journal of Medicine 170 (4), 214, 1999 | 270 | 1999 |
| The asthma–chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations S Louie, AA Zeki, M Schivo, AL Chan, KY Yoneda, M Avdalovic, ... Expert review of clinical pharmacology 6 (2), 197-219, 2013 | 248 | 2013 |
| Characteristics and outcomes of individuals with pre-existing kidney disease and COVID-19 admitted to intensive care units in the United States JE Flythe, MM Assimon, MJ Tugman, EH Chang, S Gupta, J Shah, ... American Journal of Kidney Diseases 77 (2), 190-203. e1, 2021 | 247 | 2021 |
| Tramadol exposures reported to statewide poison control system KA Marquardt, JA Alsop, TE Albertson Annals of Pharmacotherapy 39 (6), 1039-1044, 2005 | 240 | 2005 |
| From vital signs to clinical outcomes for patients with sepsis: a machine learning basis for a clinical decision support system E Gultepe, JP Green, H Nguyen, J Adams, T Albertson, I Tagkopoulos Journal of the American Medical Informatics Association 21 (2), 315-325, 2014 | 217 | 2014 |
| A review of current and novel therapies for idiopathic pulmonary fibrosis R Rafii, MM Juarez, TE Albertson, AL Chan Journal of thoracic disease 5 (1), 48, 2013 | 209 | 2013 |
| Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome JG Weg, RA Balk, RS Tharratt, SG Jenkinson, JB Shah, D Zaccardelli, ... Jama 272 (18), 1433-1438, 1994 | 182 | 1994 |
